A. Gaudin

发表

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

C. Tzourio, B. Falissard, F. Cotté, 2020, Journal of medical Internet research.

Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases.

B. Dervaux, N. Moore, F. Thiessard, 2017, Therapie.

P0747 : Health related quality of life and utility values in chronic hepatitis C patients: A cross-sectional study in France, the Uk and Germany

S. Pol, G. Milligan, A. Gaudin, 2015 .

Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review.

A. Italiano, V. Rondeau, Denis Rustand, 2019, Critical reviews in oncology/hematology.

Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin

I. Durand-zaleski, F. Cotté, A. Gaudin, 2014, Journal of medical economics.

Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment

F. Cotté, A. Gaudin, B. Cortet, 2010, BMC women's health.

Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial

A. Italiano, V. Rondeau, C. Bellera, 2021, ESMO open.

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis.

J. Penrod, F. Cotté, A. Gaudin, 2019, Lung cancer.

Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries

J. Gourmelen, J. Bonastre, F. Cotté, 2019, Journal of medical economics.

Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France

F. Cotté, A. Gaudin, V. Grumberg, 2022, Journal of medical economics.

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)

F. Cotté, A. Gaudin, V. Grumberg, 2020, Therapeutic advances in medical oncology.

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

P. Ruszniewski, J. Frexinos, M. Amouretti, 2004, Gastroenterologie clinique et biologique.

[Tools for assessing patient perception of the impact of migraine].

A. Gaudin, A. El Hasnaoui, A. Doble, 2006, CNS drugs.

Calcium intake and the risk of osteoporosis and fractures in French women.

E. Lespessailles, C. Roux, F. Cotté, 2010, Joint, bone, spine : revue du rhumatisme.

Malaria prevention behaviour and risk awareness in French adult travellers.

S. Hercberg, K. Ezzedine, D. Malvy, 2010, Travel medicine and infectious disease.

Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France

S. Roze, F. Cotté, A. Gaudin, 2020, Dermatology and Therapy.

Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study.

L. Fauchier, F. Cotté, A. Gaudin, 2016, International journal of cardiology.

Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.

I. Durand-zaleski, F. Cotté, A. Gaudin, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations

F. Cotté, A. Gaudin, H. Lemasson, 2020, Journal of medical Internet research.

F. Cotté, A. Gaudin, H. Lemasson, 2020 .

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)

I. Durand-zaleski, P. Chauvin, P. Souquet, 2017, PloS one.

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study

M. Rouprêt, C. Bellera, A. Gaudin, 2023, World journal of urology.

Management of osteoporosis and associated quality of life in post menopausal women

F. Cotté, A. Gaudin, B. Cortet, 2011, BMC musculoskeletal disorders.

Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting

F. Cotté, A. Gaudin, V. Grumberg, 2023, Therapeutic advances in medical oncology.

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis

C. Roux, C. Roux, F. Cotté, 2009, Osteoporosis International.

Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).

P. Ruszniewski, J. Frexinos, M. Amouretti, 2006, Gastroenterologie clinique et biologique.

Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study

L. Fauchier, F. Cotté, A. Gaudin, 2015, Open Heart.

Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab

J. Lortet-Tieulent, F. Cotté, A. Gaudin, 2022, JCO clinical cancer informatics.

Prevalence and features of osteoporosis in the French general population: the Instant study.

E. Lespessailles, C. Roux, F. Cotté, 2009, Joint, bone, spine : revue du rhumatisme.

Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT study.

E. Lespessailles, C. Roux, F. Cotté, 2008, Joint, bone, spine : revue du rhumatisme.

The burden cost of French patients suffering from irritable bowel syndrome

P. Ruszniewski, J. Frexinos, M. Amouretti, 2004, Scandinavian journal of gastroenterology.

A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France.

C. Roux, F. Cotté, A. Gaudin, 2008, Joint, bone, spine : revue du rhumatisme.

The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and France.

J. Cramer, A. Gaudin, M. Walker, 2006, Clinical therapeutics.

Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)

A. Gaudin, P. Combemale, B. Bregman, 2017, BMC Health Services Research.

Characterisation of Patients with Postmenopausal Osteoporosis in French Primary Healthcare

P. Hilliquin, F. Allaert, F. Cotté, 2007, Drugs & aging.

Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women

A. Regnault, B. Arnould, A. Gaudin, 2011, Osteoporosis International.

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study

M. Rouprêt, C. Bellera, A. Gaudin, 2023, World Journal of Urology.

Use and Misuse of Triptans in France: Data from the Grim2000 Population Survey

J. Dartigues, G. Chazot, A. Pradalier, 2004, Cephalalgia : an international journal of headache.

Prevalence and description of chronic daily headache in the general population in France

J. Dartigues, G. Chazot, A. Pradalier, 2003, Pain.

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

I. Durand-zaleski, P. Chauvin, P. Souquet, 2018, BMC Cancer.

[Prevalence of nocturia among people in Auxerre: the French part of the UrEpik study].

P. Boyle, A. Gaudin, R. Fourcade, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

MA07.06 Immunotherapy Re-Challenge After Nivolumab Treatment in Advanced Non-Small Cell Lung Cancer in French Real-World Setting

C. Chouaid, F. Cotté, A. Gaudin, 2019, Journal of Thoracic Oncology.

A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities

J. Borrill, S. Roze, A. Gaudin, 2022, International Journal of Technology Assessment in Health Care.

Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France.

O. Chassany, P. Auquier, I. Durand-zaleski, 2022, Therapie.

Factors associated with regular cervical cancer screening

D. Malvy, A. Gaudin, G. Grangé, 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study (Preprint)

C. Tzourio, B. Falissard, F. Cotté, 2020 .

Changes in the quality of life of advanced melanoma patients after 12 weeks of treatment with ipilimumab compared to gp100 in a phase III clinical trial.

C. Lebbé, A. Gaudin, B. Bregman, 2013 .

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France

L. Fauchier, F. Cotté, A. Gaudin, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

UP-1.09: Impact of benign prostatic hyperplasia (BPH) on medically treated patients' quality of life

C. L. Fur, F. Cotté, A. Gaudin, 2010 .

Impact of Headache on Quality of Life in a General Population Survey in France (GRIM2000 Study)

J. Dartigues, G. Chazot, A. Pradalier, 2004, Headache.

Management of lung cancer patients' quality of life in clinical practice: a Delphi study

B. Arnould, F. Cotté, A. Gaudin, 2021, ESMO open.

Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study.

L. Fauchier, F. Cotté, A. Gaudin, 2016, International journal of cardiology.

Characteristics, management, and healthcare resources of patients with advanced non–small-cell lung cancer surviving 5 years after nivolumab treatment initiation: a national database analysis

A. Gaudin, B. Jouaneton, Chouaid Christos, 2023, Respiratory Medicine and Research.

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

P. Ruszniewski, J. Frexinos, M. Amouretti, 2004, Gastroenterologie clinique et biologique.